Vedolizumab appears safe to continue in pregnancy: study

Pregnancy outcomes are similar for women who continue to use vedolizumab to maintain remission from IBD compared to those who use anti-TNF or conventional non-biologic therapies, a European study has shown. An analysis of pregnancy and neonatal outcomes for 402 women who took IBD therapies during pregnancy found no difference overall in terms of miscarriage, ...

Already a member?

Login to keep reading.

© 2021 the limbic